Abstract:We have previously identified a human CD8+HLA-DR+ regulatory T cell subset with the ability to suppress proliferation of autologous PBMCs responder cells through cell contact and CTLA-4 co-inhibitory molecule. The present study characterizes the complete phenotype of CD8+HLA-DR+ Treg cells which showed great similarities with classical CD4+ cells expressing forkhead box P3 (FOXP3). The shared features included the expression of programmed cell death protein 1 (PD-1), T-cell immunoreceptor with Ig and ITIM domains (TIGIT), C-C chemokine receptor type 4 and 5 (CCR4 and CCR5), low expression of CD127, and a memory and effector-like phenotype. CD8+HLA-DR+ Treg-induced suppression on CD8+ responder T cells was abrogated by an anti-PD1 neutralizing antibody. Anti-PD-1 did not abrogate the suppressor effect induced on responder CD4+ T cells. In addition, CD8+HLA-DR+ Treg induced a preferential death on responder CD8+ T cells. This effect was not reversed by PD-1 neutralization. After activation, most CD8+HLA-DR+ Treg acquire programmed death-ligand 1 (PD-L1) expression. Interestingly, PD-L1 may induce apoptosis through CD80 expressed on activated CD8+ responder T cells. After PBMCs stimulation, CD8+HLA-DR+ Treg cells showed an increased frequency of IFN-γ and TNFα positive cells and higher degranulation. These data strongly argue against CD8+HLA-DR+ Treg being exhausted cells. Overall, the data presented in this study indicate that CD8+HLA-DR+ Treg and CD4+FOXP3+ Treg share phenotypic and functional features, which may provide cues to similar involvements in the control of antitumor immune responses and autoimmunity.

Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

Generation Of Human Regulatory Gamma Delta T Cells By Tcr Gamma Delta Stimulation In The Presence Of Tgf-Beta And Their Involvement In The Pathogenesis Of Systemic Lupus Erythematosus

Programmed Death 1 Ligand (Pd-L) 1 And Pd-L2 Limit Autoimmune Kidney Disease: Distinct Roles

Engagement of B7 on Effector T Cells by Regulatory T Cells Prevents Autoimmune Disease.

Regulation Of Cd8(+) Regulatory T Cells: Interruption Of The Nkg2a-Qa-1 Interaction Allows Robust Suppressive Activity And Resolution Of Autoimmune Disease

Regulatory T cells suppress CD4+ T cells through NFAT-dependent transcriptional mechanisms

TGF-β-induced regulatory T cells directly suppress B cell responses through a non-cytotoxic mechanism

Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

Inhibition of follicular T-helper cells by CD8 + regulatory T cells is essential for self tolerance

Generation and Regulation of CD8(+) Regulatory T Cells.

Overexpression of Programmed Death Ligand 1 in Dendritic Cells Inhibits Allogeneic Lymphocyte Activation in Mice

Human CD8+HLA-DR+ Regulatory T Cells, Similarly to Classical CD4+Foxp3+ Cells, Suppress Immune Responses via PD-1/PD-L1 Axis

Regulatory CD4+ T cells promote B cell anergy in murine lupus.

Properties of TNFR2, PDL-1 Dependent Human CD8+ Regulatory Cells Generated Ex-Vivo That Can Be Strongly Protective in Vivo (116.4)

Suppression of lethal autoimmunity by regulatory T cells with a single TCR specificity

The Molecular Mechanisms of Regulatory T Cell Immunosuppression

Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients

Regulatory Rheumatoid Factor is Specific to PD-1 and Uses PD-1 Pathway to Control CD4 T Lymphocytes

Regulatory T cells control type 1-driven immunopathology restraining GM-CSF-producing helper T cells